Today U.S. District Court Judge Reed O’Connor issued his decision on the remedy for his September 2022 ruling that the requirement that Affordable Care Act (ACA)-compliant health insurers cover U.S. Preventive Services Task Force (USPSTF)-recommended services without cost sharing violates the U.S. Constitution.
WASHINGTON, D.C. – A bill introduced in the House today aims to improve future equitable access to new and innovative cancer screenings among Medicare beneficiaries in order to increase early detection of more cancers for more individuals.
The PSA Screening for HIM Act was introduced in the U.S. House of Representatives on March 28, 2023. This bipartisan legislative proposal would waive cost-sharing requirements for men with the highest risk of prostate cancer, focusing on Black men and those with a family history of the disease.
Today, a bipartisan, bicameral group of congressional lawmakers introduced legislation which would prohibit the use of all combustible tobacco products and the use of e-cigarettes at healthcare facilities managed by the U.S. Department of Veterans Affairs.
On behalf of cancer patients, survivors and their families, the American Cancer Society Cancer Action Network (ACS CAN) is pleased to see the president’s continued focus and dedication to achieving the goal of the Cancer Moonshot, to end cancer as we know it.
According to the most recent Survivor Views survey, cost is considered the most important factor when it comes to comparing coverage options (43%), but the right mix of covered benefits is also essential.
The American Cancer Society Cancer Action Network (ACS CAN) applauds the president’s continued focus and dedication to achieving the goal of the Cancer Moonshot, to end cancer as we know it. President Biden outlined several strategies in the State of the Union to reduce the cancer burden nationwide.
Ahead of the President’s State of the Union Address, the American Cancer Society Cancer Action Network (ACS CAN) is calling on the President to emphasize the need for continued bipartisan support for increased federal investment in the fight against cancer.
American Cancer Society and ACS CAN statement on one-year anniversary of reignition of the Cancer Moonshot Initiative.
WASHINGTON, D.C.—Early this morning Congress released a proposed FY 2023 funding deal that includes an increase of $2.5 billion for biomedical research funding at the National Institutes of Health (NIH), $408 million more for cancer research at the National Cancer Institute (NCI)